|
PITPNB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.074400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.029400E-01 |
| Normal-vs-Stage2 |
3.401000E-01 |
| Normal-vs-Stage3 |
9.048600E-01 |
| Normal-vs-Stage4 |
9.797200E-01 |
| Stage1-vs-Stage2 |
4.593600E-01 |
| Stage1-vs-Stage3 |
5.662200E-01 |
| Stage1-vs-Stage4 |
7.811800E-01 |
| Stage2-vs-Stage3 |
3.134400E-01 |
| Stage2-vs-Stage4 |
5.093200E-01 |
| Stage3-vs-Stage4 |
9.239000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.299600E-01 |
| Normal-vs-AfricanAmerican |
3.856400E-01 |
| Normal-vs-Asian |
8.619200E-01 |
| Caucasian-vs-AfricanAmerican |
6.756800E-01 |
| Caucasian-vs-Asian |
4.489200E-01 |
| AfricanAmerican-vs-Asian |
3.328200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.551200E-01 |
| Normal-vs-Female |
1.741970E-01 |
| Male-vs-Female |
2.289200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.972200E-01 |
| Normal-vs-Extreme_Weight |
5.183200E-01 |
| Normal-vs-Obese |
4.407800E-01 |
| Normal-vs-Extreme_Obese |
9.782400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.509800E-01 |
| Normal_Weight-vs-Obese |
2.980400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.358800E-01 |
| Extreme_Weight-vs-Obese |
8.686200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.362000E-01 |
| Obese-vs-Extreme_Obese |
6.693600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.519900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.592300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.951800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.878760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.713600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.389220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.480300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.694100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.158400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.011040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.198100E-02 |
| Normal-VS-Type2 PRCC |
2.628300E-02 |
| Normal-VS-KIRP CIMP |
1.095210E-01 |
| Normal-VS-Unclassified PRCC |
7.718400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.49609999997325E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.511600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.496100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.208000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.258980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.815170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.724000E-01 |
| Normal-vs-N1 |
3.763800E-01 |
| Normal-vs-N2 |
5.609600E-01 |
| N0-vs-N1 |
1.731850E-01 |
| N0-vs-N2 |
4.890000E-01 |
| N1-vs-N2 |
9.901000E-01 |
|
|
